21st Century Oncology VP of Sales Salary | Comparably
"21st Century Oncology is a provider of integrated cancer treatment services and radiation therapies for bladder, brain, breast and cervical cancer." read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
107

21st Century Oncology VP of Sales Salary

The average 21st Century Oncology VP of Sales earns an estimated $299,633 annually, which includes an estimated base salary of $196,675 with a $102,957 bonus. 21st Century Oncology's VP of Sales compensation is $2,336,564 less than the US average for a VP of Sales. VP of Sales salaries at 21st Century Oncology can range from $125,000 - $700,000.

The Sales Department at 21st Century Oncology earns $9,557 more on average than the HR Department.

Last updated 5 years ago.

$60k
$122k
$212k
$300k
$3.56B
$299,633
Average Compensation
$196,675
avg. base
$102,957
avg. bonus

VP of Sales Salaries at 21st Century Oncology

VPs of Sales earn $160,460 more than Sales Managers, and $45,730 less than Directors of Sales.

Director of Sales
$345k*
Sales Manager
$139k*
Sales Engineer
$139k*
Sales Rep
$121k*
Sales Associate
$65k*
* estimated salary

Compensation at 21st Century Oncology by Department

The Sales Department averages $9,557 more than the HR Department, and $644 less than the Design Department

Design
$109,676 Avg. total comp.
+$644
Sales
$109,032 Avg. total comp.
HR
$99,475 Avg. total comp.
-$10k

VP of Sales Compensation by Gender (All Companies)

The average female VP of Sales at companies similar size to 21st Century Oncology reported making $281,278, while the average male VP of Sales at similar sized companies reported making $323,387.

VP of Sales Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander VP of Sales at companies similar size to 21st Century Oncology reported making $340,000, while the average Hispanic or Latino VP of Sales at similar sized companies reported making $265,125.

How VPs of Sales at 21st Century Oncology Rate Their Compensation

100% say they receive annual bonuses, and the majority (33%) are not satisfied with their benefits. See more compensation ratings at 21st Century Oncology

×
Rate your company